Alumis market cap ALMS
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Nov 2, 2026
- $825.8M
- Highest close in our data
- $3.7B
- Jul 2026
Alumis is worth $825.8M at the close on Nov 2, 2026, at $6.38 a share.
That is up 68% over the last year.
Its highest close in our data was $3.7B in Jul 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $825.8M | $792.1M | $3.7B | −28% |
| 2025 | $1.1B | $155.6M | $1.2B | +161% |
| 2024 | $438.5M | $438.5M | $696.4M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Alumis' size, closest first, today.
| Company | Market cap |
|---|---|
| ALMSAlumis | $825.8M |
| ABUSArbutus Biopharma | $791.4M |
| COLLCollegium Pharmaceutical | $770.9M |
| ZVRAZevra Therapeutics | $599.8M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| IRWDIronwood Pharmaceuticals | $571.7M |
| OMEROmeros | $1.3B |
| PBYIPuma Biotechnology | $525.5M |
| ARVNArvinas | $491.7M |
| ANABAnaptysbio | $1.4B |
| PCRXPacira BioSciences | $1.5B |
| Peer median | $781.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Alumis
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.